ESMO 2022 | Dose individualization of TKIs

Joseph Ciccolini, PharmD, PhD, Aix Marseille University & La Timone University Hospital of Marseille, Marseille, France, discusses the dose individualisation of targeted therapies for precision medicine and the importance of understanding patient differences to define dosing and improve patient outcomes. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.